Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LatInamerican Vaccine Effectiveness Against Hospitalizations Due to Circulating COVID-19 VoC RWE Study

NCT05282017 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05282017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05282017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LatInamerican Vaccine Effectiveness Against Hospitalizations Due to Circulating COVID-19 VoC RWE Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 1, 2022
Completion date
April 19, 2023
Enrollment
792 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2